NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers.
Villapalos-García G, Zubiaur P, Ochoa D, Soria-Chacartegui P, Navares-Gómez M, Matas M, Mejía-Abril G, Casajús-Rey A, Campodónico D, Román M, Martín-Vílchez S, Candau-Ramos C, Aldama-Martín M, Abad-Santos F.
Villapalos-García G, et al. Among authors: navares gomez m.
Biomed Pharmacother. 2023 Sep;165:115058. doi: 10.1016/j.biopha.2023.115058. Epub 2023 Jun 28.
Biomed Pharmacother. 2023.
PMID: 37385211
Free article.